Close Menu

Researchers at Nanjing University have found miRNA signatures in blood serum, says an article in Tech Review. In work published in Cell Research, they sequenced miRNA in the blood of people with lung cancer, colorectal cancer, and diabetes and found specific expression patterns. "Whatever the reason, microRNAs are stable in the serum and are resistant to ribonuclease digestion," says lead author Chen-Yu Zhang.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.